These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 5083161)
21. The place of subtotal parathyroidectomy in the management of patients with chronic renal failure. Katz AI; Hampers CL; Wilson RE; Bernstein DS; Wachman A; Merrill JP Trans Am Soc Artif Intern Organs; 1968; 14():376-84. PubMed ID: 5701560 [No Abstract] [Full Text] [Related]
25. [Letter: Is it necessary to wait for the time of parathyroidectomy to treat the hyperparathyroidism of patients with chronic renal insufficiency]. Bernheim J; Faivre JM Nouv Presse Med; 1975 Feb; 4(8):591. PubMed ID: 1129122 [No Abstract] [Full Text] [Related]
26. Indications for parathyroidectomy in patients with chronic renal failure. Finch T; Jacobs JK Am Surg; 1974 Jan; 40(1):40-4. PubMed ID: 4808621 [No Abstract] [Full Text] [Related]
28. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3. Madsen S Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650 [No Abstract] [Full Text] [Related]
29. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone. Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749 [No Abstract] [Full Text] [Related]
30. Disappearance of vascular calcifications during treatment of renal osteodystrophy. Two patients treated with high doses of vitamin D and aluminum hydroxide. Verberckmoes R; Bouillon R; Krempien B Ann Intern Med; 1975 Apr; 82(4):529-33. PubMed ID: 1119767 [TBL] [Abstract][Full Text] [Related]
35. [Calcium metabolism disorders caused by impaired renal function]. Jørstad S Tidsskr Nor Laegeforen; 1982 Nov; 102(32):1697-700. PubMed ID: 7167940 [No Abstract] [Full Text] [Related]
36. The advantage of measurement of intact PTH in the prediction of clinical response and calcium metabolism after subtotal parathyroidectomy for renal osteodystrophy. Barth RH; Cheigh JS; Sullivan JF; Chami J; Suthanthiran M; Stubenbord WT; Stenzel KH; Rubin AL Trans Am Soc Artif Intern Organs; 1983; 29():124-8. PubMed ID: 6673220 [TBL] [Abstract][Full Text] [Related]
37. Total parathyroidectomy and autotransplantation of parathyroid tissue for renal hyperparathyroidism. A one- to six-year follow-up. Rothmund M; Wagner PK Ann Surg; 1983 Jan; 197(1):7-16. PubMed ID: 6848057 [TBL] [Abstract][Full Text] [Related]
38. Role of pyrophosphate in renal osteodystrophy. David DS; Sakai S; Granda J; Cheigh JS; Riggio RR; Stenzel KH; Rubin AL Trans Am Soc Artif Intern Organs; 1973; 19():440-5. PubMed ID: 4352991 [No Abstract] [Full Text] [Related]